EVAX stock
Evaxion Biotech AS (EVAX) institutional holders · rev $7.5M
Evaxion Biotech AS institutional holders from SEC Form 13F, top 1 by reported value. Each row is the filer's newest 13F for quarters ended 2026-03-31 or later, share lines summed, options excluded; value is the 13F-reported market value in US dollars. Rows marked Prior quarter are filers whose 2026-06-30 13F is not cached yet.
| Holder | Shares | Value | Report |
|---|---|---|---|
| CITADEL ADVISORS LLC | 17,773 | $66.1K | 2026-03-31Prior quarter |
EVAX institutional holders FAQ
What is EVAX's latest revenue?
Latest cached Evaxion Biotech AS (EVAX) revenue for Dec 31, 2025 was $7.5M. Statements: https://lician.com/financials/evax
Not investment advice. Figures as filed or reported, not a live feed.